“The Food and Drug Administration (FDA) may incorporate blockchain to improve drug and medical products reviews and recalls.”
“In a speech at the Office of the National Coordinator for Health IT Third Interoperability Forum, on August 22, principal deputy commissioner Dr. Amy Abernethy, said the FDA is looking to modernize the way health care providers, drug manufacturers, and regulatory agencies communicate.”
“Without going into details, Abernethy said the agency plans to roll out uses of artificial intelligence, APIs and blockchain in this modernization effort. Improved interoperability – how the agency handles and shares information – may affect the reviewal process for new medicines…”
“Abernethy also alluded to a communication system where regulators are provided with real-time information and data…” Read the full article here.
Source: Blockchain May Be Used in FDA Medical Reviews and Recalls – By Daniel Kuhn, August 23, 2019. CoinDesk.
